5.62% 0.8398

Eton Pharmaceuticals Inc (ETON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Eton Pharmaceuticals Inc

Healthcare (1167)

(847) 787-7361

21925 W. FIELD PARKWAY, DEER PARK, IL

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ETON's Discussions on Twitter

Vergleichen Sie ETON mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ETON Eton Pharmaceuticals Inc	15.43	386.98M	31.38M	-6.69M	-1.84M	-0.26
ZTS Zoetis Inc	152.78	68.05B	9.29B	2.52B	2.28B	5.57
TAK Takeda Pharmaceutical Co Adr	14.77	46.58B	30.08B	710.16M	4.45B	0.2182
HLN Haleon Plc Adr	9.745	43.71B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	16.50	18.40B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	305.38	13.23B	2.99B	1.21B	1.13B	25.06

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-23	Bestätigt	H.C. Wainwright	Buy
2025-01-10	Eingeleitet	B. Riley Securities	Buy
2025-01-06	Bestätigt	H.C. Wainwright	Buy
2024-09-04	Fortgesetzt	H.C. Wainwright	Buy
2024-05-06	Eingeleitet	Craig Hallum	Buy
2021-10-14	Fortgesetzt	B. Riley Securities	Buy
2021-01-04	Bestätigt	H.C. Wainwright	Buy
2019-09-20	Eingeleitet	B. Riley FBR	Buy
2019-06-10	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten

Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)

Eton Pharmaceuticals Inc-Aktie (ETON) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Krempa David	Chief Business Officer	Jun 16 '25	Sale	14.73	10,223	150,585	612,646
Krempa David	Chief Business Officer	Jun 13 '25	Sale	14.77	6,800	100,436	622,869
Opaleye Management Inc.	10% Owner	Jun 10 '25	Buy	15.82	7,930	125,484	2,770,000

Eton Pharmaceuticals Inc (ETON)

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Vergleichen Sie ETON mit anderen Aktien

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten

What analysts say about Eton Pharmaceuticals Inc. stockLightning-fast capital gains - jammulinksnews.com

Eton Pharmaceuticals Inc. Stock Analysis and ForecastBreakthrough financial growth - jammulinksnews.com

Is Eton Pharmaceuticals Inc. a good long term investmentRapid return acceleration - jammulinksnews.com

What drives Eton Pharmaceuticals Inc. stock priceExtraordinary profit generation - jammulinksnews.com

What makes Eton Pharmaceuticals Inc. stock price move sharplyHigh Yield Opportunities - Newser

Top Growth Companies With Insider Stakes July 2025 - simplywall.st

B. Riley Analysts Lift Earnings Estimates for ETON - Defense World

B. Riley Boosts Earnings Estimates for Eton Pharmaceuticals - Defense World

ETON’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

How Eton Pharmaceuticals Inc. stock performs during market volatilityLow Risk Profit Ideas - Newser

Why Eton Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Preservation Investment Ideas - Newser

Eton Pharmaceuticals: A Contrarian Play on Delayed Catalysts and Long-Term Value - AInvest

Eton Pharma Near Term Catalysts Vanish (NASDAQ:ETON) - Seeking Alpha

(ETON) Trading Report - news.stocktradersdaily.com

Institutional investors are Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) biggest bettors and were rewarded after last week's US$48m market cap gain - simplywall.st

FDA accepts Eton’s NDA for ET-600 desmopressin oral solution By Investing.com - Investing.com South Africa

Eton Pharmaceuticals Announces Fda Acceptance of New Drug Application for Et-600 (Desmopressin Oral Solution) - MarketScreener

Eton stock gains as new therapy gets FDA review (ETON) - Seeking Alpha

Eton Pharmaceuticals announces FDA acceptance of new drug application for ET-600 - MarketScreener

FDA accepts Eton’s NDA for ET-600 desmopressin oral solution - Investing.com

Eton Pharmaceuticals Announces FDA Acceptance of NDA for ET-600 with Target Action Date of February 25, 2026 - Quiver Quantitative

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) - The Manila Times

Eton's New Pediatric Drug Solution Advances Toward FDA Approval, Targeting $1B Market Opportunity - Stock Titan

Eton Pharmaceuticals to join Russell indexes - MSN

Eton Pharmaceuticals (ETON) to Join Russell 3000 and 2000 Indexes | ETON Stock News - GuruFocus

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes - The Manila Times

ETON switches auditor: Crowe LLP out, Grant Thornton in – no disputes | ETON SEC FilingForm 8-K - Stock Titan

Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc. - GuruFocus

Insiders Back These 3 High Growth Companies - Yahoo Finance

Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) 25% Cheaper Price Remains In Tune With Revenues - simplywall.st

Bank of America Corp DE Boosts Stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World

Insider Sell: David Krempa Sells 34,000 Shares of Eton Pharmaceu - GuruFocus

Insider Sell: David Krempa Sells 34,000 Shares of Eton Pharmaceuticals Inc (ETON) - GuruFocus

Eton Pharma wins FDA nod for oral hydrocortisone solution - MSN

Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency - MSN

Major Shareholder Increases Stake in Eton Pharmaceuticals! - TipRanks

Eton Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Trend Tracker for (ETON) - news.stocktradersdaily.com

B. Riley Forecasts Higher Earnings for Eton Pharmaceuticals - Defense World

Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside - Seeking Alpha

Insider Sell: Sean Brynjelsen Sells 210,000 Shares of Eton Pharm - GuruFocus

Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)

Umsatz

Nettogewinn

Free Cashflow

ENV

Eton Pharmaceuticals Inc-Aktie (ETON) Insiderhandel

Ähnlich wie ETON